Justin Sharry

Midlothian US-VA
[email protected]

CEO at Syntyche, Inc.

Summary

Entrepreneurial Executive offering 9 years of Medical Sales and Management experience. Results-focused leader with proven ability to turnaround struggling territories efficiently and within budget. Seeking a leadership position within a medical device or pharmaceutical company.

Work experience

Dec 2009Present

CEO and Member, Board of Directors

Syntyche, Inc.

Responsibilities:
- Currently direct all operations and national business strategy for myRepLunch.com, automating the coordination of medical vendor-client meetings
- Responsible for attracting initial investors and closing first round of seed investment
- Directed product and customer development from Alpha through public launch
- Oversee board of directors and established the company's first formal board of advisors
- Responsible for hiring outside sales reps and contract negotiations with over 130 national restaurant providers
- Currently negotiating the company's Series A round of institutional investment

Mar 2006Dec 2009

Territory Manager, Medtronic Diabetes

Medtronic, Inc.

Responsibilities:
- Increase sales of Insulin Pumps, Continuous Glucose Monitoring systems and disposables
- Managed one nurse and associate sales representative, including account targeting and development, budgeting, and sales analysis

Call points:
- Endocrinologists, Cardiologists, Diabetes Treatment Facilities and Hospital C-Suite

Performance:
- 101% to Insulin Pump Revenue, FY'09
- 169% to Glucose Systems Revenue, FY'09
- 101.4% to Insulin Pump Revenue, FY'08
- 121.4% to Glucose Systems Revenue, FY'08
- 99.65% to Insulin Pump Revenue, FY'07

Ranking:
- Ranked: 5/207, Glucose Product Sales, FY'09
- Ranked Overall: 66/207, FY'09
- Ranked Overall: 71/218, FY'08
- Ranked Overall: 156/204, FY'07

Awards:
- Diabetes Management Consultant of the Quarter, Q1 FY'08
- District of the Year, FY'09
- Carelink Champion, FY'09 (1 of 12 in the company)

May 2004Mar 2006

Senior Pharmaceutical Sales Specialist

GlaxoSmithKline Pharmaceuticals

Responsibilities:Responsible for selling the multiple portfolios to physicians including:
- Coreg: Cardiology
- Requip: Neurology
- Avandia/Avandamet/Avandaryl: Diabetes
- Avodart: Urology
- Advair and Flonase: Respiratory

Performance:
- Ranked: 146/537 (top 27%), FY'05
- Successfully launched Requip to 425% of target, Fall, 2005
- Increased sales of Advair to 147.7% of target, Winter 2005
- Increased sales of Advair to 224.8% of target, Spring 2005
- Increased sales of Flonase to 143.9% of target, Spring 2005
Special Projects:
- Developed an Automated Office Analysis Tool, April 2005
  - Presented as best practice to Vice President of Sales
- Coordinated Multi-District Collaborative Calendar Initiative, April 2005
  - Presented as best practice to Vice President of Sales

Jul 2002May 2004

Pharmaceutical Sales Specialist

AstraZeneca Pharmaceuticals

Responsibilities:Responsible for selling the Cardiology and Respiratory portfolios including:
- Toprol XL, Atacand, Crestor: Cardiology
- Pulmocort Respules: Pediatric Respiratory

Performance:
- Increased Toprol XL Market Share by 56%, Sep 2002 - May 2004
- Increased Atacand Market Share by 32%, Sep 2002 - May 2004
- Received 9 awards for outstanding performance, Aug 2002 - May 2004